We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current CLLS market cap is 168.15M. The company's latest EPS is USD -1.0097 and P/E is -1.67.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.6M | 1.99M | 6.53M | 10.19M | 18.23M |
| Operating Income | -14.64M | -29.58M | -20.9M | -17.21M | -10.77M |
| Net Income | -6.04M | -61.63M | 5.64M | -25.27M | -23.06M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 22.99M | 82.46M | 67.58M | 27.67M | 9.24M |
| Operating Income | -123.55M | -85.44M | -130.68M | -110.85M | -108.2M |
| Net Income | -102.09M | -81.07M | -114.2M | -106.14M | -101.06M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 0 | 0 | 354.46M | 407.15M | 395.88M |
| Total Liabilities | 0 | 0 | 263.89M | 258.54M | 266.45M |
| Total Equity | 0 | 0 | 90.57M | 148.61M | 129.42M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 467.47M | 469.47M | 382.08M | 261.22M | 334.27M |
| Total Liabilities | 112M | 160.63M | 145.6M | 135.28M | 249.58M |
| Total Equity | 355.47M | 308.85M | 236.47M | 125.94M | 84.7M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | N/A | N/A | -23.32M | 28.87M | 23.04M |
| Investing | N/A | N/A | -2.05M | -108.48M | -86.15M |
| Financing | N/A | N/A | 11.9M | 90.41M | 86.19M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -69.14M | -80.26M | -104.56M | -87.44M | -24.75M |
| Investing | -35.87M | -54.34M | 7.28M | -2.76M | -15.51M |
| Financing | -3.86M | 27.32M | 47.53M | 1.15M | 82.86M |
| Market Cap | 168.15M |
| Price to Earnings Ratio | -1.67 |
| Price to Sales Ratio | 18.31 |
| Price to Cash Ratio | 1.24 |
| Price to Book Ratio | 2 |
| Dividend Yield | - |
| Shares Outstanding | 100.09M |
| Average Volume (1 week) | 239.64k |
| Average Volume (1 Month) | 225.24k |
| 52 Week Change | -38.91% |
| 52 Week High | 3.38 |
| 52 Week Low | 1.41 |
| Spread (Intraday) | 0.09 (5.17%) |
| Company Name | Cellectis SA |
| Address |
8 rue de la croix- jarry paris, paris 75013 |
| Website | https://www.cellectis.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
